Q00535 (CDK5_HUMAN) Homo sapiens (Human)
Cyclin-dependent kinase 5 UniProtKBInterProSTRINGInteractive Modelling
Available Structures
10 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Structural mechanism for the inhibition of CD5-p25 from the roscovitine, aloisine and indirubin. |
Heteromer Q15078; | 99.66 | 1×RRC; | |||
| Structural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin. |
Heteromer Q15078; | 99.65 | 1×ALH; | |||
| The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 1 |
Heteromer Q15078; | 100.0 | 1×65L; 10×EDO; 2×PEG; 7×CL; 1×GOL; | |||
| The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 13 |
Heteromer Q15078; | 100 | 1×63I; 1×PGE; 9×EDO; | |||
| The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 7 |
Heteromer Q15078; | 100 | 1×64V; | |||
| The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 24 |
Heteromer Q15078; | 100 | 1×61U; 8×GOL; 17×EDO; 19×CL; | |||
| Crystal Structure of Cdk5:p25 in complex with an ATP analogue |
Heteromer Q15078; | 99.65 | ||||
| Structural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin. |
Heteromer Q15078; | 99.64 | 1×IXM; | |||
| Structure and regulation of the CDK5-p25(nck5a) complex |
Heteromer Q15078; | 99.64 | ||||
| Crystal structure of compound 4a in complex with cdk5, showing an unusual binding mode to the hinge… | monomer | 100.0 | 3×SO4; 1×Z3R; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7vdq.1.A | monomer | 0.89 | 1×64V; | 100.00 | ||
1 SWISS-MODEL model built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 3o0g.1.A | monomer | 0.82 | 99.62 | |||